E91* (p.Glu91Ter) variant of ABL2 (Tyrosine-protein kinase ABL2)
E91* (p.Glu91Ter) in ABL2 (Tyrosine-protein kinase ABL2) is a protein-truncating change. Clinical records from UniProt describe it as variant assessed as somatic; high impact.
E91* (p.Glu91Ter) variant details
- p.Glu91Ter
- NCI-TCGA Cosmic COSV6101
- cosmic curated COSV61017
- Variant assessed as somatic; high impact.
- Stop Gained
- UniProt: Variant assessed as somatic; high impact.